• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of cmrPermissionsJournals.ASM.orgJournalCMR ArticleJournal InfoAuthorsReviewers
Clin Microbiol Rev. Jan 1996; 9(1): 55–71.
PMCID: PMC172882

Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum.

Abstract

The pathogenic potential of Fusobacterium nucleatum and its significance in the development of periodontal diseases, as well as in infections in other organs, have gained new interest for several reasons. First, this bacterium has the potential to be pathogenic because of its number and frequency in periodontal lesions, its production of tissue irritants, its synergism with other bacteria in mixed infections, and its ability to form aggregates with other suspected pathogens in periodontal disease and thus act as a bridge between early and late colonizers on the tooth surface. Second, of the microbial species that are statistically associated with periodontal disease, F. nucleatum is the most common in clinical infections of other body sites. Third, during the past few years, new techniques have made it possible to obtain more information about F. nucleatum on the genetic level, thereby also gaining better knowledge of the structure and functions of the outer membrane proteins (OMPs). OMPs are of great interest with respect to coaggregation, cell nutrition, and antibiotic susceptibility. This review covers what is known to date about F. nucleatum in general, such as taxonomy and biology, with special emphasis on its pathogenic potential. Its possible relationship to other periodontal bacteria in the development of periodontal diseases and the possible roles played by OMPs are considered.

Full Text

The Full Text of this article is available as a PDF (775K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abraham SN, Beachey EH, Simpson WA. Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun. 1983 Sep;41(3):1261–1268. [PMC free article] [PubMed]
  • Abu Fanas SH, Drucker DB, Hull PS. Amoxycillin with clavulanic acid and tetracycline in periodontal therapy. J Dent. 1991 Apr;19(2):97–99. [PubMed]
  • Abu-Fanas SH, Drucker DB, Hull PS, Reeder JC, Ganguli LA. Identification, and susceptibility to seven antimicrobial agents, of 61 gram-negative anaerobic rods from periodontal pockets. J Dent. 1991 Feb;19(1):46–50. [PubMed]
  • Albandar JM, Olsen I, Gjermo P. Associations between six DNA probe-detected periodontal bacteria and alveolar bone loss and other clinical signs of periodontitis. Acta Odontol Scand. 1990 Dec;48(6):415–423. [PubMed]
  • Ali RW, Bakken V, Nilsen R, Skaug N. Comparative detection frequency of 6 putative periodontal pathogens in Sudanese and Norwegian adult periodontitis patients. J Periodontol. 1994 Nov;65(11):1046–1052. [PubMed]
  • Ali RW, Skaug N, Nilsen R, Bakken V. Microbial associations of 4 putative periodontal pathogens in Sudanese adult periodontitis patients determined by DNA probe analysis. J Periodontol. 1994 Nov;65(11):1053–1057. [PubMed]
  • Appelbaum PC, Spangler SK, Jacobs MR. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam. J Antimicrob Chemother. 1993 Aug;32(2):223–231. [PubMed]
  • Asikainen S, Jousimies-Somer H, Kanervo A, Summanen P. Certain bacterial species and morphotypes in localized juvenile periodontitis and in matched controls. J Periodontol. 1987 Apr;58(4):224–230. [PubMed]
  • Attström R, Egelberg J. Emigration of blood neutrophils and monocytes into the gingival crevices. J Periodontal Res. 1970;5(1):48–55. [PubMed]
  • Azen E, Prakobphol A, Fisher SJ. PRB3 null mutations result in absence of the proline-rich glycoprotein Gl and abolish Fusobacterium nucleatum interactions with saliva in vitro. Infect Immun. 1993 Oct;61(10):4434–4439. [PMC free article] [PubMed]
  • Baardsen R, Bakken V, Jensen HB, Hofstad T. Outer membrane protein pattern of Eubacterium plautii. J Gen Microbiol. 1988 Jun;134(6):1561–1564. [PubMed]
  • Bagg J, Silverwood RW. Coagglutination reactions between Candida albicans and oral bacteria. J Med Microbiol. 1986 Sep;22(2):165–169. [PubMed]
  • Baker PJ, Coburn RA, Genco RJ, Evans RT. Structural determinants of activity of chlorhexidine and alkyl bisbiguanides against the human oral flora. J Dent Res. 1987 Jun;66(6):1099–1106. [PubMed]
  • Bakken V, Aarø S, Hofstad T, Vasstrand EN. Outer membrane proteins as major antigens of Fusobacterium nucleatum. FEMS Microbiol Immunol. 1989 Dec;1(8-9):473–483. [PubMed]
  • Bakken V, Aarø S, Jensen HB. Purification and partial characterization of a major outer-membrane protein of Fusobacterium nucleatum. J Gen Microbiol. 1989 Dec;135(12):3253–3262. [PubMed]
  • Bakken V, Högh BT, Jensen HB. Utilization of amino acids and peptides by Fusobacterium nucleatum. Scand J Dent Res. 1989 Feb;97(1):43–53. [PubMed]
  • Bakken V, Högh BT, Jensen HB. Growth conditions and outer membrane proteins of Fusobacterium nucleatum. Scand J Dent Res. 1990 Jun;98(3):215–224. [PubMed]
  • Bakken V, Jensen HB. Outer membrane proteins of Fusobacterium nucleatum Fev1. J Gen Microbiol. 1986 Apr;132(4):1069–1078. [PubMed]
  • Barker HA, Kahn JM, Hedrick L. Pathway of lysine degradation in Fusobacterium nucleatum. J Bacteriol. 1982 Oct;152(1):201–207. [PMC free article] [PubMed]
  • Bartold PM, Gully NJ, Zilm PS, Rogers AH. Identification of components in Fusobacterium nucleatum chemostat-culture supernatants that are potent inhibitors of human gingival fibroblast proliferation. J Periodontal Res. 1991 Jul;26(4):314–322. [PubMed]
  • Baumgartner JC, Falkler WA, Jr, Beckerman T. Experimentally induced infection by oral anaerobic microorganisms in a mouse model. Oral Microbiol Immunol. 1992 Aug;7(4):253–256. [PubMed]
  • Beatrix B, Bendrat K, Rospert S, Buckel W. The biotin-dependent sodium ion pump glutaconyl-CoA decarboxylase from Fusobacterium nucleatum (subsp. nucleatum). Comparison with the glutaconyl-CoA decarboxylases from gram-positive bacteria. Arch Microbiol. 1990;154(4):362–369. [PubMed]
  • Beer KB, Miller VL. Amino acid substitutions in naturally occurring variants of ail result in altered invasion activity. J Bacteriol. 1992 Feb;174(4):1360–1369. [PMC free article] [PubMed]
  • Bennett KW, Eley A. Fusobacteria: new taxonomy and related diseases. J Med Microbiol. 1993 Oct;39(4):246–254. [PubMed]
  • Bick PH, Carpenter AB, Holdeman LV, Miller GA, Ranney RR, Palcanis KG, Tew JG. Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites. Infect Immun. 1981 Oct;34(1):43–49. [PMC free article] [PubMed]
  • Bird PS, Seymour GJ. Production of monoclonal antibodies that recognize specific and cross-reactive antigens of Fusobacterium nucleatum. Infect Immun. 1987 Mar;55(3):771–777. [PMC free article] [PubMed]
  • Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res. 1993 Nov;28(6 Pt 2):500–510. [PubMed]
  • Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol. 1993 May;64(5 Suppl):474–484. [PubMed]
  • Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4(2):197–250. [PubMed]
  • Blaser MJ, Hopkins JA, Vasil ML. Campylobacter jejuni outer membrane proteins are antigenic for humans. Infect Immun. 1984 Mar;43(3):986–993. [PMC free article] [PubMed]
  • Bolstad AI. Sizing the Fusobacterium nucleatum genome by pulsed-field gel electrophoresis. FEMS Microbiol Lett. 1994 Oct 15;123(1-2):145–151. [PubMed]
  • Bolstad AI, Høgh BT, Jensen HB. Molecular characterization of a 40-kDa outer membrane protein, FomA, of Fusobacterium periodonticum and comparison with Fusobacterium nucleatum. Oral Microbiol Immunol. 1995 Oct;10(5):257–264. [PubMed]
  • Bolstad AI, Jensen HB. Complete sequence of omp1, the structural gene encoding the 40-kDa outer membrane protein of Fusobacterium nucleatum strain Fev1. Gene. 1993 Sep 30;132(1):107–112. [PubMed]
  • Bolstad AI, Jensen HB. Methylation of adenine and cytosine in some strains of Fusobacterium nucleatum. Microb Pathog. 1993 Feb;14(2):117–121. [PubMed]
  • Bolstad AI, Jensen HB. Polymerase chain reaction-amplified nonradioactive probes for identification of Fusobacterium nucleatum. J Clin Microbiol. 1993 Mar;31(3):528–532. [PMC free article] [PubMed]
  • Bolstad AI, Kleivdal H, Jensen HB. Similarities between Fusobacterium nucleatum and bacteroides fragilis studied by two DNA probes derived from Fusobacterium nucleatum. Scand J Dent Res. 1994 Feb;102(1):5–9. [PubMed]
  • Bolstad AI, Skaug N, Jensen HB. Use of synthetic oligonucleotide DNA probes for the identification of different strains of Fusobacterium nucleatum. J Periodontal Res. 1991 Nov;26(6):519–526. [PubMed]
  • Bolstad AI, Tommassen J, Jensen HB. Sequence variability of the 40-kDa outer membrane proteins of Fusobacterium nucleatum strains and a model for the topology of the proteins. Mol Gen Genet. 1994 Jul 8;244(1):104–110. [PubMed]
  • Brokstad KA, Bakken V, Vasstrand EN, Jensen HB. Diisopropylfluorophosphate-binding proteins in the outer membrane of Fusobacterium nucleatum: strain variations. FEMS Microbiol Lett. 1990 Jan 1;54(1-3):235–238. [PubMed]
  • Brokstad KA, Jensen HB. Purification and characterization of a 65-kilodalton diisopropylfluorophosphate-binding protein in the outer membrane of Fusobacterium nucleatum Fev1. Scand J Dent Res. 1991 Feb;99(1):20–29. [PubMed]
  • Brook I. Fusobacterial infections in children. J Infect. 1994 Mar;28(2):155–165. [PubMed]
  • Brook I. The role of encapsulated anaerobic bacteria in synergistic infections. FEMS Microbiol Rev. 1994 Jan;13(1):65–74. [PubMed]
  • Brook I, Walker RI. The relationship between Fusobacterium species and other flora in mixed infection. J Med Microbiol. 1986 Mar;21(2):93–100. [PubMed]
  • Buckel W, Barker HA. Two pathways of glutamate fermentation by anaerobic bacteria. J Bacteriol. 1974 Mar;117(3):1248–1260. [PMC free article] [PubMed]
  • Calhoon DA, Mayberry WR, Slots J. Cellular fatty acid and soluble protein profiles of oral fusobacteria. J Dent Res. 1983 Dec;62(12):1181–1185. [PubMed]
  • Carlsson J, Larsen JT, Edlund MB. Utilization of glutathione (L-gamma-glutamyl-L-cysteinylglycine) by Fusobacterium nucleatum subspecies nucleatum. Oral Microbiol Immunol. 1994 Oct;9(5):297–300. [PubMed]
  • Chaim W, Mazor M. Intraamniotic infection with fusobacteria. Arch Gynecol Obstet. 1992;251(1):1–7. [PubMed]
  • Childs WC, 3rd, Gibbons RJ. Selective modulation of bacterial attachment to oral epithelial cells by enzyme activities associated with poor oral hygiene. J Periodontal Res. 1990 May;25(3):172–178. [PubMed]
  • Christersson LA, Zambon JJ, Genco RJ. Dental bacterial plaques. Nature and role in periodontal disease. J Clin Periodontol. 1991 Jul;18(6):441–446. [PubMed]
  • Claesson R, Edlund MB, Persson S, Carlsson J. Production of volatile sulfur compounds by various Fusobacterium species. Oral Microbiol Immunol. 1990 Jun;5(3):137–142. [PubMed]
  • Cohen SP, McMurry LM, Levy SB. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol. 1988 Dec;170(12):5416–5422. [PMC free article] [PubMed]
  • Conway B, Ronald A. An overview of some mechanisms of bacterial pathogenesis. Can J Microbiol. 1988 Mar;34(3):281–286. [PubMed]
  • Cowan SW, Schirmer T, Rummel G, Steiert M, Ghosh R, Pauptit RA, Jansonius JN, Rosenbusch JP. Crystal structures explain functional properties of two E. coli porins. Nature. 1992 Aug 27;358(6389):727–733. [PubMed]
  • Crippin JS, Wang KK. An unrecognized etiology for pyogenic hepatic abscesses in normal hosts: dental disease. Am J Gastroenterol. 1992 Dec;87(12):1740–1743. [PubMed]
  • da Costa T, Bier LC, Gaida F. Dextran hydrolysis by a Fusobacterium strain isolated from human dental plaque. Arch Oral Biol. 1974 Apr;19(4):341–342. [PubMed]
  • Dahlén G, Nygren H, Hannsson HA. Immunoelectron microscopic localization of lipopolysaccharides in the cell wall of Bacteroides oralis and Fusobacterium nucleatum. Infect Immun. 1978 Jan;19(1):265–271. [PMC free article] [PubMed]
  • Danielsen B, Wilton JM, Baelum V, Johnson NW, Fejerskov O. Serum immunoglobulin G antibodies to Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum and Streptococcus sanguis during experimental gingivitis in young adults. Oral Microbiol Immunol. 1993 Jun;8(3):154–160. [PubMed]
  • Dehazya P, Coles RS., Jr Agglutination of human erythrocytes by Fusobacterium nucleatum: factors influencing hemagglutination and some characteristics of the agglutinin. J Bacteriol. 1980 Jul;143(1):205–211. [PMC free article] [PubMed]
  • Dehazya P, Coles RS., Jr Extraction and properties of hemagglutinin from cell wall fragments of Fusobacterium nucleatum. J Bacteriol. 1982 Oct;152(1):298–305. [PMC free article] [PubMed]
  • De Jong MH, Van der Hoeven JS. The growth of oral bacteria on saliva. J Dent Res. 1987 Feb;66(2):498–505. [PubMed]
  • de Kort G, Bolton A, Martin G, Stephen J, van de Klundert JA. Invasion of rabbit ileal tissue by Enterobacter cloacae varies with the concentration of OmpX in the outer membrane. Infect Immun. 1994 Nov;62(11):4722–4726. [PMC free article] [PubMed]
  • DiRienzo JM, Rosan B. Isolation of a major cell envelope protein from Fusobacterium nucleatum. Infect Immun. 1984 May;44(2):386–393. [PMC free article] [PubMed]
  • Dix K, Watanabe SM, McArdle S, Lee DI, Randolph C, Moncla B, Schwartz DE. Species-specific oligodeoxynucleotide probes for the identification of periodontal bacteria. J Clin Microbiol. 1990 Feb;28(2):319–323. [PMC free article] [PubMed]
  • Donaldson SL, Ranney RR, Tew JG. Evidence of mitogenic activity in periodontitis-associated bacteria. Infect Immun. 1983 Nov;42(2):487–495. [PMC free article] [PubMed]
  • Dzink JL, Sheenan MT, Socransky SS. Proposal of three subspecies of Fusobacterium nucleatum Knorr 1922: Fusobacterium nucleatum subsp. nucleatum subsp. nov., comb. nov.; Fusobacterium nucleatum subsp. polymorphum subsp. nov., nom. rev., comb. nov.; and Fusobacterium nucleatum subsp. vincentii subsp. nov., nom. rev., comb. nov. Int J Syst Bacteriol. 1990 Jan;40(1):74–78. [PubMed]
  • Dzink JL, Socransky SS. Amino acid utilization by Fusobacterium nucleatum grown in a chemically defined medium. Oral Microbiol Immunol. 1990 Jun;5(3):172–174. [PubMed]
  • Dzink JL, Socransky SS, Haffajee AD. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol. 1988 May;15(5):316–323. [PubMed]
  • Dzink JL, Tanner AC, Haffajee AD, Socransky SS. Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol. 1985 Sep;12(8):648–659. [PubMed]
  • Elhag KM, Alkarmi TO. A study of the antigenic composition of the fragilis group of Bacteroides. J Med Microbiol. 1991 Aug;35(2):118–122. [PubMed]
  • Ellen RP, Song M, Buivids IA. Inhibition of Actinomyces viscosus--Porphyromonas gingivalis coadhesion by trypsin and other proteins. Oral Microbiol Immunol. 1992 Aug;7(4):198–203. [PubMed]
  • Falkler WA, Jr, Burger BW. Microbial surface interactions: reduction of the haemagglutination activity of the oral bacterium Fusobacterium nucleatum by absorption with Streptococcus and Bacteroides. Arch Oral Biol. 1981;26(12):1015–1025. [PubMed]
  • Falkler WA, Jr, Clayman EB, Shaefer DF. Haemolysis of human erythrocytes by the Fusobacterium nucleatum associated with periodontal disease. Arch Oral Biol. 1983;28(8):735–739. [PubMed]
  • Falkler WA, Jr, Hawley CE. Hemagglutinating activity of Fusobacterium nucleatum. Infect Immun. 1977 Jan;15(1):230–238. [PMC free article] [PubMed]
  • Falkler WA, Jr, Lai R, Vincent JW, Dober L, Spiegel C, Hayduk S. The ELISA system for measuring antibody reactive to Fusobacterium nucleatum in the sera of patients with chronic periodontitis. J Periodontol. 1982 Dec;53(12):762–766. [PubMed]
  • Falkler WA, Jr, Montgomery J, Nauman RK, Alpers M. Isolation of Fusobacterium nucleatum and electron microscopic observations of spirochetes from tropical skin ulcers in Papua New Guinea. Am J Trop Med Hyg. 1989 Apr;40(4):390–398. [PubMed]
  • Falkler WA, Jr, Smoot CN, Mongiello JR. Attachment of cell fragments of Fusobacterium nucleatum to oral epithelial cells, gingival fibroblasts and white blood cells. Arch Oral Biol. 1982;27(7):553–559. [PubMed]
  • Fredriksen A, Vasstrand EN, Jensen HB. Peptidoglycan precursor from Fusobacterium nucleatum contains lanthionine. J Bacteriol. 1991 Jan;173(2):900–902. [PMC free article] [PubMed]
  • Fredriksen G, Hofstad T. Chemotypes of Fusobacterium nucleatum lipopolysaccharides. Acta Pathol Microbiol Scand B. 1978 Feb;86(1):41–45. [PubMed]
  • Frisken KW, Higgins T, Palmer JM. The incidence of periodontopathic microorganisms in young children. Oral Microbiol Immunol. 1990 Feb;5(1):43–45. [PubMed]
  • Frisken KW, Tagg JR, Laws AJ, Orr MB. Suspected periodontopathic microorganisms and their oral habitats in young children. Oral Microbiol Immunol. 1987 Jun;2(2):60–64. [PubMed]
  • Gemmell E, Seymour GJ. Different responses in B cells induced by Porphyromonas gingivalis and Fusobacterium nucleatum. Arch Oral Biol. 1992;37(7):565–573. [PubMed]
  • Gemmell E, Seymour GJ. Interleukin 1, interleukin 6 and transforming growth factor-beta production by human gingival mononuclear cells following stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. J Periodontal Res. 1993 Mar;28(2):122–129. [PubMed]
  • Gemmell E, Seymour GJ. Modulation of immune responses to periodontal bacteria. Curr Opin Periodontol. 1994:28–38. [PubMed]
  • Genco RJ, Loos BG. The use of genomic DNA fingerprinting in studies of the epidemiology of bacteria in periodontitis. J Clin Periodontol. 1991 Jul;18(6):396–405. [PubMed]
  • George AM, Levy SB. Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol. 1983 Aug;155(2):531–540. [PMC free article] [PubMed]
  • George KS, Falkler WA., Jr Coaggregation studies of the Eubacterium species. Oral Microbiol Immunol. 1992 Oct;7(5):285–290. [PubMed]
  • George WL, Kirby BD, Sutter VL, Citron DM, Finegold SM. Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera. Rev Infect Dis. 1981 May-Jun;3(3):599–626. [PubMed]
  • Gharbia SE, Shah HN. Comparison of the amino acid uptake profile of reference and clinical isolates of Fusobacterium nucleatum subspecies. Oral Microbiol Immunol. 1991 Oct;6(5):264–269. [PubMed]
  • Gharbia SE, Shah HN. Fusobacterium nucleatum subsp. fusiforme subsp. nov. and Fusobacterium nucleatum subsp. animalis subsp. nov. as additional subspecies within Fusobacterium nucleatum. Int J Syst Bacteriol. 1992 Apr;42(2):296–298. [PubMed]
  • Gharbia SE, Shah HN, Lawson PA, Haapasalo M. Distribution and frequency of Fusobacterium nucleatum subspecies in the human oral cavity. Oral Microbiol Immunol. 1990 Dec;5(6):324–327. [PubMed]
  • Gibbons RJ. Bacterial adhesion to oral tissues: a model for infectious diseases. J Dent Res. 1989 May;68(5):750–760. [PubMed]
  • Gibbons RJ, Hay DI, Childs WC, 3rd, Davis G. Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral surfaces. Arch Oral Biol. 1990;35 (Suppl):107S–114S. [PubMed]
  • Gibbons RJ, van Houte J. Selective bacterial adherence to oral epithelial surfaces and its role as an ecological determinant. Infect Immun. 1971 Apr;3(4):567–573. [PMC free article] [PubMed]
  • Gillece-Castro BL, Prakobphol A, Burlingame AL, Leffler H, Fisher SJ. Structure and bacterial receptor activity of a human salivary proline-rich glycoprotein. J Biol Chem. 1991 Sep 15;266(26):17358–17368. [PubMed]
  • Gilleland HE, Jr, Parker MG, Matthews JM, Berg RD. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun. 1984 Apr;44(1):49–54. [PMC free article] [PubMed]
  • González-Gay MA, Sánchez-Andrade A, Cereijo MJ, Pulpeiro JR, Armesto V. Pyomyositis and septic arthritis from Fusobacterium nucleatum in a nonimmunocompromised adult. J Rheumatol. 1993 Mar;20(3):518–520. [PubMed]
  • Goodson JM, Tanner A, McArdle S, Dix K, Watanabe SM. Multicenter evaluation of tetracycline fiber therapy. III. Microbiological response. J Periodontal Res. 1991 Sep;26(5):440–451. [PubMed]
  • Granlund-Edstedt M, Johansson E, Claesson R, Carlsson J. Effect of anaerobiosis and sulfide on killing of bacteria by polymorphonuclear leukocytes. J Periodontal Res. 1993 Sep;28(5):346–353. [PubMed]
  • Grant ME, Heathcote JG, Orkin RW. Current concepts of basement-membrane structure and function. Biosci Rep. 1981 Nov;1(11):819–842. [PubMed]
  • Grenier D. Demonstration of a bimodal coaggregation reaction between Porphyromonas gingivalis and Treponema denticola. Oral Microbiol Immunol. 1992 Oct;7(5):280–284. [PubMed]
  • Grenier D, Mayrand D. Nutritional relationships between oral bacteria. Infect Immun. 1986 Sep;53(3):616–620. [PMC free article] [PubMed]
  • Grollier G, Guilhot F, de Rautlin de la Roy Y, Benz-Lemoine E. A penicillinase-producing Fusobacterium nucleatum strain isolated from blood culture. Eur J Clin Microbiol. 1987 Dec;6(6):695–696. [PubMed]
  • Gunsolley JC, Tew JG, Gooss C, Marshall DR, Burmeister JA, Schenkein HA. Serum antibodies to periodontal bacteria. J Periodontol. 1990 Jul;61(7):412–419. [PubMed]
  • Haffajee AD, Socransky SS, Dzink JL, Taubman MA, Ebersole JL, Smith DJ. Clinical, microbiological and immunological features of subjects with destructive periodontal diseases. J Clin Periodontol. 1988 Apr;15(4):240–246. [PubMed]
  • Haffajee AD, Socransky SS, Smith C, Dibart S. Relation of baseline microbial parameters to future periodontal attachment loss. J Clin Periodontol. 1991 Nov;18(10):744–750. [PubMed]
  • Hall ER, Martin SA, Suzuki JB, Falkler WA., Jr The gingival immune response to periodontal pathogens in juvenile periodontitis. Oral Microbiol Immunol. 1994 Dec;9(6):327–334. [PubMed]
  • Hamada S, Koga T, Nishihara T, Fujiwara T, Okahashi N. Characterization and immunobiologic activities of lipopolysaccharides from periodontal bacteria. Adv Dent Res. 1988 Nov;2(2):284–291. [PubMed]
  • HAMPP EG, SCOTT DB, WYCKOFF RW. Morphological characteristics of oral fusobacteria as revealed by the electron microscope. J Bacteriol. 1960 May;79:716–728. [PMC free article] [PubMed]
  • Handley PS, Carter PL, Wyatt JE, Hesketh LM. Surface structures (peritrichous fibrils and tufts of fibrils) found on Streptococcus sanguis strains may be related to their ability to coaggregate with other oral genera. Infect Immun. 1985 Jan;47(1):217–227. [PMC free article] [PubMed]
  • Harder KJ, Nikaido H, Matsuhashi M. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob Agents Chemother. 1981 Oct;20(4):549–552. [PMC free article] [PubMed]
  • Hase S, Hofstad T, Rietschel ET. Chemical structure of the lipid A component of lipopolysaccharides from Fusobacterium nucleatum. J Bacteriol. 1977 Jan;129(1):9–14. [PMC free article] [PubMed]
  • Hasty DL, Ofek I, Courtney HS, Doyle RJ. Multiple adhesins of streptococci. Infect Immun. 1992 Jun;60(6):2147–2152. [PMC free article] [PubMed]
  • Hedberg M, Lindqvist L, Tunér K, Nord CE. Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum. J Antimicrob Chemother. 1992 Jul;30(1):17–25. [PubMed]
  • Hiratsuka K, Abiko Y, Hayakawa M, Ito T, Sasahara H, Takiguchi H. Role of Porphyromonas gingivalis 40-kDa outer membrane protein in the aggregation of P. gingivalis vesicles and Actinomyces viscosus. Arch Oral Biol. 1992 Sep;37(9):717–724. [PubMed]
  • Hoepelman AI, Tuomanen EI. Consequences of microbial attachment: directing host cell functions with adhesins. Infect Immun. 1992 May;60(5):1729–1733. [PMC free article] [PubMed]
  • Hofstad T. Serological responses to antigens of Bacteroidaceae. Microbiol Rev. 1979 Mar;43(1):103–115. [PMC free article] [PubMed]
  • Hofstad T, Aadnegard B. Oligosaccharides obtained by partial hydrolysis of lipopolysaccharide from Fusobacterium nucleatum F1. J Periodontal Res. 1986 Mar;21(2):163–168. [PubMed]
  • Hofstad T, Skaug N. Fatty acids and neutral sugars present in lipopolysaccharides isolated from Fusobacterium species. Acta Pathol Microbiol Scand B. 1980 Apr;88(2):115–120. [PubMed]
  • Hofstad T, Skaug N, Bjørnland T. O-antigenic cross-reactivity in Fusobacterium nucleatum. Acta Pathol Microbiol Scand B. 1979 Dec;87(6):371–374. [PubMed]
  • Holt SC, Bramanti TE. Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med. 1991;2(2):177–281. [PubMed]
  • Hooper DC, Wolfson JS, Souza KS, Tung C, McHugh GL, Swartz MN. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob Agents Chemother. 1986 Apr;29(4):639–644. [PMC free article] [PubMed]
  • Horiba N, Maekawa Y, Yamauchi Y, Ito M, Matsumoto T, Nakamura H. Complement activation by lipopolysaccharides purified from gram-negative bacteria isolated from infected root canals. Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):648–651. [PubMed]
  • Ishii T, Mahanonda R, Seymour GJ. The establishment of human T cell lines reactive with specific periodontal bacteria. Oral Microbiol Immunol. 1992 Aug;7(4):225–229. [PubMed]
  • Isogai E, Hirose K, Fujii N, Isogai H. Three types of binding by Porphyromonas gingivalis and oral bacteria to fibronectin, buccal epithelial cells and erythrocytes. Arch Oral Biol. 1992 Aug;37(8):667–670. [PubMed]
  • Isogai E, Isogai H, Sawada H, Kaneko H, Ito N. Microbial ecology of plaque in rats with naturally occurring gingivitis. Infect Immun. 1985 May;48(2):520–527. [PMC free article] [PubMed]
  • Jacobs MR, Spangler SK, Appelbaum PC. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole. Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):417–421. [PubMed]
  • Jacobs MR, Spangler SK, Appelbaum PC. beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1081–1093. [PubMed]
  • Jantzen E, Hofstad T. Fatty acids of Fusobacterium species: taxonomic implications. J Gen Microbiol. 1981 Mar;123(1):163–171. [PubMed]
  • Jennings ML. Topography of membrane proteins. Annu Rev Biochem. 1989;58:999–1027. [PubMed]
  • Kato T, Okuda T, Takazoe I. Cross-reactive monoclonal antibodies induced by LPS from periodontopathic bacteria. Adv Dent Res. 1988 Nov;2(2):319–322. [PubMed]
  • Kato T, Takazoe I, Okuda K. Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies. Infect Immun. 1989 Feb;57(2):656–659. [PMC free article] [PubMed]
  • Kaufman J, DiRienzo JM. Evidence for the existence of two classes of corncob (coaggregation) receptor in Fusobacterium nucleatum. Oral Microbiol Immunol. 1988 Dec;3(4):145–152. [PubMed]
  • Kaufman J, DiRienzo JM. Isolation of a corncob (coaggregation) receptor polypeptide from Fusobacterium nucleatum. Infect Immun. 1989 Feb;57(2):331–337. [PMC free article] [PubMed]
  • Kaur M, Falkler WA., Jr Characterization of shared antigens of Fusobacterium nucleatum and Fusobacterium necrophorum. Oral Microbiol Immunol. 1992 Oct;7(5):291–298. [PubMed]
  • Kelstrup J, Theilade J, Fejerskov O. Surface ultrastructure of some oral bacteria. Scand J Dent Res. 1979 Dec;87(6):415–423. [PubMed]
  • Kerosuo E, Haapasalo M, Alli K, Lounatmaa K. Ingestion of Bacteroides buccae, Bacteroides oris, Porphyromonas gingivalis, and Fusobacterium nucleatum by human polymorphonuclear leukocytes in vitro. Oral Microbiol Immunol. 1990 Aug;5(4):202–207. [PubMed]
  • Kinane DF. Metalloproteinases in the pathogenesis of periodontal diseases. Curr Opin Dent. 1992 Mar;2:25–32. [PubMed]
  • Kinder SA, Holt SC. Characterization of coaggregation between Bacteroides gingivalis T22 and Fusobacterium nucleatum T18. Infect Immun. 1989 Nov;57(11):3425–3433. [PMC free article] [PubMed]
  • Kinder SA, Holt SC. Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggregation with Porphyromonas gingivalis T22. J Bacteriol. 1993 Feb;175(3):840–850. [PMC free article] [PubMed]
  • Kjeldsen M, Holmstrup P, Bendtzen K. Marginal periodontitis and cytokines: a review of the literature. J Periodontol. 1993 Nov;64(11):1013–1022. [PubMed]
  • Klees AG, Linder D, Buckel W. 2-Hydroxyglutaryl-CoA dehydratase from Fusobacterium nucleatum (subsp. nucleatum): an iron-sulfur flavoprotein. Arch Microbiol. 1992;158(4):294–301. [PubMed]
  • Kleivdal H, Benz R, Jensen HB. The Fusobacterium nucleatum major outer-membrane protein (FomA) forms trimeric, water-filled channels in lipid bilayer membranes. Eur J Biochem. 1995 Oct 1;233(1):310–316. [PubMed]
  • Klimpel KW, Clark VL. The RNA polymerases of Porphyromonas gingivalis and Fusobacterium nucleatum are unrelated to the RNA polymerase of Escherichia coli. J Dent Res. 1990 Sep;69(9):1567–1572. [PubMed]
  • Kolenbrander PE. Intergeneric coaggregation among human oral bacteria and ecology of dental plaque. Annu Rev Microbiol. 1988;42:627–656. [PubMed]
  • Kolenbrander PE. Surface recognition among oral bacteria: multigeneric coaggregations and their mediators. Crit Rev Microbiol. 1989;17(2):137–159. [PubMed]
  • Kolenbrander PE, Andersen RN. Multigeneric aggregations among oral bacteria: a network of independent cell-to-cell interactions. J Bacteriol. 1986 Nov;168(2):851–859. [PMC free article] [PubMed]
  • Kolenbrander PE, Andersen RN. Inhibition of coaggregation between Fusobacterium nucleatum and Porphyromonas (Bacteroides) gingivalis by lactose and related sugars. Infect Immun. 1989 Oct;57(10):3204–3209. [PMC free article] [PubMed]
  • Kolenbrander PE, Andersen RN, Holdeman LV. Coaggregation of oral Bacteroides species with other bacteria: central role in coaggregation bridges and competitions. Infect Immun. 1985 Jun;48(3):741–746. [PMC free article] [PubMed]
  • Kolenbrander PE, Andersen RN, Moore LV. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect Immun. 1989 Oct;57(10):3194–3203. [PMC free article] [PubMed]
  • Kolenbrander PE, Andersen RN, Moore LV. Intrageneric coaggregation among strains of human oral bacteria: potential role in primary colonization of the tooth surface. Appl Environ Microbiol. 1990 Dec;56(12):3890–3894. [PMC free article] [PubMed]
  • Kolenbrander PE, Ganeshkumar N, Cassels FJ, Hughes CV. Coaggregation: specific adherence among human oral plaque bacteria. FASEB J. 1993 Mar;7(5):406–413. [PubMed]
  • Kolenbrander PE, London J. Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol. 1993 Jun;175(11):3247–3252. [PMC free article] [PubMed]
  • Könönen E, Asikainen S, Saarela M, Karjalainen J, Jousimies-Somer H. The oral gram-negative anaerobic microflora in young children: longitudinal changes from edentulous to dentate mouth. Oral Microbiol Immunol. 1994 Jun;9(3):136–141. [PubMed]
  • Kristoffersen T, Maeland JA, Hofstad T. Serologic properties of lipopolysaccharide endotoxins from oral fusobacteria. Scand J Dent Res. 1971;79(2):105–112. [PubMed]
  • Kuritza AP, Getty CE, Shaughnessy P, Hesse R, Salyers AA. DNA probes for identification of clinically important Bacteroides species. J Clin Microbiol. 1986 Feb;23(2):343–349. [PMC free article] [PubMed]
  • Lamster IB, Celenti R, Ebersole JL. The relationship of serum IgG antibody titers to periodontal pathogens to indicators of the host response in crevicular fluid. J Clin Periodontol. 1990 Aug;17(7 Pt 1):419–425. [PubMed]
  • Lancy P, Jr, Dirienzo JM, Appelbaum B, Rosan B, Holt SC. Corncob formation between Fusobacterium nucleatum and Streptococcus sanguis. Infect Immun. 1983 Apr;40(1):303–309. [PMC free article] [PubMed]
  • Lawson PA, Gharbia SE, Shah HN, Clark DR. Recognition of Fusobacterium nucleatum subgroups Fn-1, Fn-2 and Fn-3 by ribosomal RNA gene restriction patterns. FEMS Microbiol Lett. 1989 Nov;53(1-2):41–45. [PubMed]
  • Lawson PA, Gharbia SE, Shah HN, Clark DR, Collins MD. Intrageneric relationships of members of the genus Fusobacterium as determined by reverse transcriptase sequencing of small-subunit rRNA. Int J Syst Bacteriol. 1991 Jul;41(3):347–354. [PubMed]
  • Liljenberg B, Lindhe J, Berglundh T, Dahlén G, Jonsson R. Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease. J Clin Periodontol. 1994 Nov;21(10):720–727. [PubMed]
  • Loesche WJ, Gibbons RJ. Amino acid fermentation by Fusobacterium nucleatum. Arch Oral Biol. 1968 Feb;13(2):191–202. [PubMed]
  • Lopatin DE, Blackburn E. Sensitization with Fusobacterium nucleatum targets antibody-dependent cellular cytotoxicity to mammalian cells. Infect Immun. 1986 Jun;52(3):650–656. [PMC free article] [PubMed]
  • Lopatin DE, Martel LM, Mangan DF. Microbe-induced lymphocyte blastogenesis enhancement after preculture. Infect Immun. 1985 Apr;48(1):159–164. [PMC free article] [PubMed]
  • Lugtenberg B, Van Alphen L. Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim Biophys Acta. 1983 Mar 21;737(1):51–115. [PubMed]
  • Maiden MF, Tanner A, McArdle S, Najpauer K, Goodson JM. Tetracycline fiber therapy monitored by DNA probe and cultural methods. J Periodontal Res. 1991 Sep;26(5):452–459. [PubMed]
  • Mallison SM, 3rd, Smith JP, Schenkein HA, Tew JG. Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation. Infect Immun. 1991 Nov;59(11):4019–4025. [PMC free article] [PubMed]
  • Mallison SM, 3rd, Szakal AK, Ranney RR, Tew JG. Antibody synthesis specific for nonoral antigens in inflamed gingiva. Infect Immun. 1988 Apr;56(4):823–830. [PMC free article] [PubMed]
  • Mangan DF, Lopatin DE. Polyclonal activation of human peripheral blood B lymphocytes by Fusobacterium nucleatum. Infect Immun. 1983 Jun;40(3):1104–1111. [PMC free article] [PubMed]
  • Mangan DF, Novak MJ, Vora SA, Mourad J, Kriger PS. Lectinlike interactions of Fusobacterium nucleatum with human neutrophils. Infect Immun. 1989 Nov;57(11):3601–3611. [PMC free article] [PubMed]
  • Mangan DF, Won T, Lopatin DE. Nonspecific induction of immunoglobulin M antibodies to periodontal disease-associated microorganisms after polyclonal human B-lymphocyte activation by Fusobacterium nucleatum. Infect Immun. 1983 Sep;41(3):1038–1045. [PMC free article] [PubMed]
  • Mangan DF, Won T, Lopatin DE. Monocyte suppression of Fusobacterium nucleatum-induced human polyclonal B-lymphocyte activation. Infect Immun. 1984 Nov;46(2):332–339. [PMC free article] [PubMed]
  • Mergenhagen SE, Sandberg AL, Chassy BM, Brennan MJ, Yeung MK, Donkersloot JA, Cisar JO. Molecular basis of bacterial adhesion in the oral cavity. Rev Infect Dis. 1987 Sep-Oct;9 (Suppl 5):S467–S474. [PubMed]
  • Moncla BJ, Braham P, Hillier SL. Sialidase (neuraminidase) activity among gram-negative anaerobic and capnophilic bacteria. J Clin Microbiol. 1990 Mar;28(3):422–425. [PMC free article] [PubMed]
  • Mongiello JR, Falkler WA., Jr Sugar inhibition of oral Fusobacterium nucleatum haemagglutination and cell binding. Arch Oral Biol. 1979;24(7):539–545. [PubMed]
  • Moore LV, Moore WE, Cato EP, Smibert RM, Burmeister JA, Best AM, Ranney RR. Bacteriology of human gingivitis. J Dent Res. 1987 May;66(5):989–995. [PubMed]
  • Moore WE. Microbiology of periodontal disease. J Periodontal Res. 1987 Sep;22(5):335–341. [PubMed]
  • Moore WE, Holdeman LV, Cato EP, Good IJ, Smith EP, Ranney RR, Palcanis KG. Variation in periodontal floras. Infect Immun. 1984 Dec;46(3):720–726. [PMC free article] [PubMed]
  • Moore WE, Holdeman LV, Cato EP, Smibert RM, Burmeister JA, Palcanis KG, Ranney RR. Comparative bacteriology of juvenile periodontitis. Infect Immun. 1985 May;48(2):507–519. [PMC free article] [PubMed]
  • Moore WE, Holdeman LV, Smibert RM, Cato EP, Burmeister JA, Palcanis KG, Ranney RR. Bacteriology of experimental gingivitis in children. Infect Immun. 1984 Oct;46(1):1–6. [PMC free article] [PubMed]
  • Moore WE, Holdeman LV, Smibert RM, Good IJ, Burmeister JA, Palcanis KG, Ranney RR. Bacteriology of experimental gingivitis in young adult humans. Infect Immun. 1982 Nov;38(2):651–667. [PMC free article] [PubMed]
  • Moore WE, Holdeman LV, Smibert RM, Hash DE, Burmeister JA, Ranney RR. Bacteriology of severe periodontitis in young adult humans. Infect Immun. 1982 Dec;38(3):1137–1148. [PMC free article] [PubMed]
  • Moore WE, Moore LV. The bacteria of periodontal diseases. Periodontol 2000. 1994 Jun;5:66–77. [PubMed]
  • Moore WE, Moore LH, Ranney RR, Smibert RM, Burmeister JA, Schenkein HA. The microflora of periodontal sites showing active destructive progression. J Clin Periodontol. 1991 Nov;18(10):729–739. [PubMed]
  • Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. Adv Immunol. 1979;28:293–450. [PubMed]
  • Mortimer PG, Piddock LJ. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemother. 1993 Aug;32(2):195–213. [PubMed]
  • Murray PA, Kern DG, Winkler JR. Identification of a galactose-binding lectin on Fusobacterium nucleatum FN-2. Infect Immun. 1988 May;56(5):1314–1319. [PMC free article] [PubMed]
  • Naito Y, Okuda K, Takazoe I. Immunoglobulin G response to subgingival gram-negative bacteria in human subjects. Infect Immun. 1984 Jul;45(1):47–51. [PMC free article] [PubMed]
  • Newman HN. Plaque and chronic inflammatory periodontal disease. A question of ecology. J Clin Periodontol. 1990 Sep;17(8):533–541. [PubMed]
  • Nikaido H, Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985 Mar;49(1):1–32. [PMC free article] [PubMed]
  • Norling T, Lading P, Engström S, Larsson K, Krog N, Nissen SS. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J Clin Periodontol. 1992 Oct;19(9 Pt 2):687–692. [PubMed]
  • Ohmori Y, Honda K, Kikuchu H, Hanazawa S, Amano S, Hirose K, Takeshita A, Katoh T, Kitano S. Inducing effect of periodontopathic bacteria on interleukin-1 production by mouse peritoneal macrophages. Oral Microbiol Immunol. 1988 Dec;3(4):169–172. [PubMed]
  • Okuda K, Kato T, Ishihara K, Naito Y. Adherence to experimental pellicle of rough-type lipopolysaccharides from subgingival plaque bacteria. Oral Microbiol Immunol. 1991 Aug;6(4):241–245. [PubMed]
  • Olsen GJ, Woese CR, Overbeek R. The winds of (evolutionary) change: breathing new life into microbiology. J Bacteriol. 1994 Jan;176(1):1–6. [PMC free article] [PubMed]
  • Anda P, Rodríguez I, de la Loma A, Fernández MV, Lozano A. A serological survey and review of clinical Lyme borreliosis in Spain. Clin Infect Dis. 1993 Feb;16(2):310–319. [PubMed]
  • Ozaki M, Miyake Y, Shirakawa M, Takemoto T, Okamoto H, Suginaka H. Binding specificity of Fusobacterium nucleatum to human erythrocytes, polymorphonuclear leukocytes, fibroblasts, and HeLa cells. J Periodontal Res. 1990 May;25(3):129–134. [PubMed]
  • Papapanou PN, Sellén A, Wennström JL, Dahlén G. An analysis of the subgingival microflora in randomly selected subjects. Oral Microbiol Immunol. 1993 Feb;8(1):24–29. [PubMed]
  • Persson S, Edlund MB, Claesson R, Carlsson J. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol Immunol. 1990 Aug;5(4):195–201. [PubMed]
  • Pianotti R, Lachette S, Dills S. Desulfuration of cysteine and methionine by Fusobacterium nucleatum. J Dent Res. 1986 Jun;65(6):913–917. [PubMed]
  • Potts TV, Holdeman LV, Slots J. Relationships among the oral fusobacteria assessed by DNA-DNA hybridization. J Dent Res. 1983 Jun;62(6):702–705. [PubMed]
  • Prakobphol A, Murray PA, Fisher SJ. Bacterial adherence on replicas of sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem. 1987 Jul;164(1):5–11. [PubMed]
  • Pugsley AP, Schnaitman CA. Outer membrane proteins of Escherichia coli. VII. Evidence that bacteriophage-directed protein 2 functions as a pore. J Bacteriol. 1978 Mar;133(3):1181–1189. [PMC free article] [PubMed]
  • Pulkkinen WS, Miller SI. A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J Bacteriol. 1991 Jan;173(1):86–93. [PMC free article] [PubMed]
  • Ribot S, Gal K, Goldblat MV, Eslami HH. The role of anaerobic bacteria in the pathogenesis of urinary tract infections. J Urol. 1981 Dec;126(6):852–853. [PubMed]
  • Riley M, Anilionis A. Evolution of the bacterial genome. Annu Rev Microbiol. 1978;32:519–560. [PubMed]
  • Ritz HL. Microbial population shifts in developing human dental plaque. Arch Oral Biol. 1967 Dec;12(12):1561–1568. [PubMed]
  • Roberts MC, Lansciardi J. Transferable Tet M in Fusobacterium nucleatum. Antimicrob Agents Chemother. 1990 Sep;34(9):1836–1838. [PMC free article] [PubMed]
  • Roberts MC, Moncla BJ. Tetracycline resistance and TetM in oral anaerobic bacteria and Neisseria perflava-N. sicca. Antimicrob Agents Chemother. 1988 Aug;32(8):1271–1273. [PMC free article] [PubMed]
  • Robrish SA, Oliver C, Thompson J. Amino acid-dependent transport of sugars by Fusobacterium nucleatum ATCC 10953. J Bacteriol. 1987 Sep;169(9):3891–3897. [PMC free article] [PubMed]
  • Robrish SA, Oliver C, Thompson J. Sugar metabolism by fusobacteria: regulation of transport, phosphorylation, and polymer formation by Fusobacterium mortiferum ATCC 25557. Infect Immun. 1991 Dec;59(12):4547–4554. [PMC free article] [PubMed]
  • Robrish SA, Thompson J. Regulation of fructose metabolism and polymer synthesis by Fusobacterium nucleatum ATCC 10953. J Bacteriol. 1990 Oct;172(10):5714–5723. [PMC free article] [PubMed]
  • Rogers AH, Gully NJ, Pfennig AL, Zilm PS. The breakdown and utilization of peptides by strains of Fusobacterium nucleatum. Oral Microbiol Immunol. 1992 Oct;7(5):299–303. [PubMed]
  • Rogers AH, Zilm PS, Gully NJ, Pfennig AL, Marsh PD. Aspects of the growth and metabolism of Fusobacterium nucleatum ATCC 10953 in continuous culture. Oral Microbiol Immunol. 1991 Aug;6(4):250–255. [PubMed]
  • Rosenbusch JP. Structural and functional properties of porin channels in E. coli outer membranes. Experientia. 1990 Feb 15;46(2):167–173. [PubMed]
  • Rossano F, Rizzo A, Sanges MR, Cipollaro de L'Ero G, Tufano MA. Human monocytes and gingival fibroblasts release tumor necrosis factor-alpha, interleukin-1 alpha and interleukin-6 in response to particulate and soluble fractions of Prevotella melaninogenica and Fusobacterium nucleatum. Int J Clin Lab Res. 1993;23(3):165–168. [PubMed]
  • Rowland MD, Del Bene VE, Lewis JW. Factors affecting antimicrobial susceptibility of Fusobacterium species. J Clin Microbiol. 1987 Mar;25(3):476–479. [PMC free article] [PubMed]
  • Savitt ED, Socransky SS. Distribution of certain subgingival microbial species in selected periodontal conditions. J Periodontal Res. 1984 Mar;19(2):111–123. [PubMed]
  • Sawai T, Hiruma R, Kawana N, Kaneko M, Taniyasu F, Inami A. Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob Agents Chemother. 1982 Oct;22(4):585–592. [PMC free article] [PubMed]
  • Scoular A, Corcoran GD, Malin A, Evans BA, Davies A, Miller RF. Fusobacterium nucleatum bacteraemia with multiple liver abscesses in an HIV-I antibody positive man with IgG2 deficiency. J Infect. 1992 May;24(3):321–325. [PubMed]
  • Seow WK, Seymour GJ, Thong YH. Direct modulation of human neutrophil adherence by coaggregating periodontopathic bacteria. Int Arch Allergy Appl Immunol. 1987;83(2):121–128. [PubMed]
  • Seymour GJ. Possible mechanisms involved in the immunoregulation of chronic inflammatory periodontal disease. J Dent Res. 1987 Jan;66(1):2–9. [PubMed]
  • Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res. 1993 Nov;28(6 Pt 2):478–486. [PubMed]
  • Shah HN, Gharbia SE. Ecological events in subgingival dental plaque with reference to Bacteroides and Fusobacterium species. Infection. 1989 Jul-Aug;17(4):264–268. [PubMed]
  • O'Donnell JG, Sorbello AF, Condoluci DV, Barnish MJ. Sinusitis due to Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Clin Infect Dis. 1993 Mar;16(3):404–406. [PubMed]
  • Shammas NW, Murphy GW, Eichelberger J, Klee D, Schwartz R, Bachman W. Infective endocarditis due to Fusobacterium nucleatum: case report and review of the literature. Clin Cardiol. 1993 Jan;16(1):72–75. [PubMed]
  • Sharp PM, Cowe E, Higgins DG, Shields DC, Wolfe KH, Wright F. Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and Homo sapiens; a review of the considerable within-species diversity. Nucleic Acids Res. 1988 Sep 12;16(17):8207–8211. [PMC free article] [PubMed]
  • Shenker BJ. Immunologic dysfunction in the pathogenesis of periodontal diseases. J Clin Periodontol. 1987 Oct;14(9):489–498. [PubMed]
  • Shenker BJ, DiRienzo JM. Suppression of human peripheral blood lymphocytes by Fusobacterium nucleatum. J Immunol. 1984 May;132(5):2357–2362. [PubMed]
  • Singer RE, Buckner BA. Butyrate and propionate: important components of toxic dental plaque extracts. Infect Immun. 1981 May;32(2):458–463. [PMC free article] [PubMed]
  • Skopek RJ, Liljemark WF, Bloomquist CG, Rudney JD. Dental plaque development on defined streptococcal surfaces. Oral Microbiol Immunol. 1993 Feb;8(1):16–23. [PubMed]
  • Slots J, Potts TV, Mashimo PA. Fusobacterium periodonticum, a new species from the human oral cavity. J Dent Res. 1983 Sep;62(9):960–963. [PubMed]
  • Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol. 1990 Aug;17(7 ):479–493. [PubMed]
  • Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol. 1992 Apr;63(4 Suppl):322–331. [PubMed]
  • Socransky SS, Haffajee AD, Dzink JL. Relationship of subgingival microbial complexes to clinical features at the sampled sites. J Clin Periodontol. 1988 Aug;15(7):440–444. [PubMed]
  • Socransky SS, Haffajee AD, Dzink JL, Hillman JD. Associations between microbial species in subgingival plaque samples. Oral Microbiol Immunol. 1988 Mar;3(1):1–7. [PubMed]
  • Socransky SS, Haffajee AD, Smith GL, Dzink JL. Difficulties encountered in the search for the etiologic agents of destructive periodontal diseases. J Clin Periodontol. 1987 Nov;14(10):588–593. [PubMed]
  • Söder PO, Jin LJ, Söder B. DNA probe detection of periodontopathogens in advanced periodontitis. Scand J Dent Res. 1993 Dec;101(6):363–370. [PubMed]
  • Sorsa T, Ingman T, Suomalainen K, Haapasalo M, Konttinen YT, Lindy O, Saari H, Uitto VJ. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun. 1992 Nov;60(11):4491–4495. [PMC free article] [PubMed]
  • Spangler SK, Jacobs MR, Appelbaum PC. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria. Antimicrob Agents Chemother. 1994 Nov;38(11):2599–2604. [PMC free article] [PubMed]
  • Speer BS, Shoemaker NB, Salyers AA. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev. 1992 Oct;5(4):387–399. [PMC free article] [PubMed]
  • Stern IB. Current concepts of the dentogingival junction: the epithelial and connective tissue attachments to the tooth. J Periodontol. 1981 Sep;52(9):465–476. [PubMed]
  • Stevens RH, Hammond BF. The comparative cytotoxicity of periodontal bacteria. J Periodontol. 1988 Nov;59(11):741–749. [PubMed]
  • Stewart-Tull DE. The immunological activities of bacterial peptidoglycans. Annu Rev Microbiol. 1980;34:311–340. [PubMed]
  • Struyvé M, Visser J, Adriaanse H, Benz R, Tommassen J. Topology of PhoE porin: the 'eyelet' region. Mol Microbiol. 1993 Jan;7(1):131–140. [PubMed]
  • Sundqvist G. Associations between microbial species in dental root canal infections. Oral Microbiol Immunol. 1992 Oct;7(5):257–262. [PubMed]
  • Sveen K. The capacity of lipopolysaccharides from bacteroides, fusobacterium and veillonella to produce skin inflammation and the local and generalized Shwartzman reaction in rabbits. J Periodontal Res. 1977 Sep;12(5):340–350. [PubMed]
  • Sveen K, Hofstad T, Milner KC. Lethality for mice and chick embryos, pyrogenicity in rabbits and ability to gelate lysate from amoebocytes of Limulus polyphemus by lipopolysaccharides from Bacteroides, Fusobacterium and Veillonella. Acta Pathol Microbiol Scand B. 1977 Dec;85B(6):388–396. [PubMed]
  • Takada H, Ogawa T, Yoshimura F, Otsuka K, Kokeguchi S, Kato K, Umemoto T, Kotani S. Immunobiological activities of a porin fraction isolated from Fusobacterium nucleatum ATCC 10953. Infect Immun. 1988 Apr;56(4):855–863. [PMC free article] [PubMed]
  • Takahashi N, Eisenhuth G, Lee I, Laible N, Binion S, Schachtele C. Immunoglobulins in milk from cows immunized with oral strains of Actinomyces, Prevotella, Porphyromonas, and Fusobacterium. J Dent Res. 1992 Aug;71(8):1509–1515. [PubMed]
  • Takemoto T, Ozaki M, Shirakawa M, Hino T, Okamoto H. Purification of arginine-sensitive hemagglutinin from Fusobacterium nucleatum and its role in coaggregation. J Periodontal Res. 1993 Jan;28(1):21–26. [PubMed]
  • Tanner A, Bouldin H. The microbiota of early periodontitis lesions in adults. J Clin Periodontol. 1989 Aug;16(7):467–471. [PubMed]
  • Tanner A, Maiden MF, Paster BJ, Dewhirst FE. The impact of 16S ribosomal RNA-based phylogeny on the taxonomy of oral bacteria. Periodontol 2000. 1994 Jun;5:26–51. [PubMed]
  • Tanner AC, Socransky SS, Goodson JM. Microbiota of periodontal pockets losing crestal alveolar bone. J Periodontal Res. 1984 May;19(3):279–291. [PubMed]
  • Taubman MA, Stoufi ED, Seymour GJ, Smith DJ, Ebersole JL. Immunoregulatory aspects of periodontal disease. Adv Dent Res. 1988 Nov;2(2):328–333. [PubMed]
  • Tew J, Engel D, Mangan D. Polyclonal B-cell activation in periodontitis. J Periodontal Res. 1989 Jul;24(4):225–241. [PubMed]
  • Tew JG, Marshall DR, Moore WE, Best AM, Palcanis KG, Ranney RR. Serum antibody reactive with predominant organisms in the subgingival flora of young adults with generalized severe periodontitis. Infect Immun. 1985 May;48(2):303–311. [PMC free article] [PubMed]
  • Tew JG, Thomas SS, Ranney RR. Fusobacterium nucleatum-mediated immunomodulation of the in vitro secondary antibody response to tetanus toxoid and Actinobacillus actinomycetemcomitans. J Periodontal Res. 1987 Nov;22(6):506–512. [PubMed]
  • Tolo K, Schenck K. Activity of serum immunoglobulins G, A, and M to six anaerobic, oral bacteria in diagnosis of periodontitis. J Periodontal Res. 1985 Mar;20(2):113–121. [PubMed]
  • Tonzetich J. Production and origin of oral malodor: a review of mechanisms and methods of analysis. J Periodontol. 1977 Jan;48(1):13–20. [PubMed]
  • Truant AL, Menge S, Milliorn K, Lairscey R, Kelly MT. Fusobacterium nucleatum pericarditis. J Clin Microbiol. 1983 Feb;17(2):349–351. [PMC free article] [PubMed]
  • Tunér K, Baron EJ, Summanen P, Finegold SM. Cellular fatty acids in Fusobacterium species as a tool for identification. J Clin Microbiol. 1992 Dec;30(12):3225–3229. [PMC free article] [PubMed]
  • Tunér K, Lindqvist L, Nord CE. Characterization of a new beta-lactamase from Fusobacterium nucleatum by substrate profiles and chromatofocusing patterns. J Antimicrob Chemother. 1985 Jul;16(1):23–30. [PubMed]
  • Tuttle RS, Mangan DF. Interaction of Fusobacterium nucleatum 191 with human peripheral blood lymphocytes. J Periodontal Res. 1990 Nov;25(6):364–371. [PubMed]
  • Tuttle RS, Strubel NA, Mourad J, Mangan DF. A non-lectin-like mechanism by which Fusobacterium nucleatum 10953 adheres to and activates human lymphocytes. Oral Microbiol Immunol. 1992 Apr;7(2):78–83. [PubMed]
  • Van Dyke TE, Bartholomew E, Genco RJ, Slots J, Levine MJ. Inhibition of neutrophil chemotaxis by soluble bacterial products. J Periodontol. 1982 Aug;53(8):502–508. [PubMed]
  • van Palenstein Helderman WH. Is antibiotic therapy justified in the treatment of human chronic inflammatory periodontal disease? J Clin Periodontol. 1986 Nov;13(10):932–938. [PubMed]
  • Vasstrand EN. Lysozyme digestion and chemical characterization of the peptidoglycan of Fusobacterium nucleatum Fev 1. Infect Immun. 1981 Jul;33(1):75–82. [PMC free article] [PubMed]
  • Vasstrand EN, Hofstad T, Endresen C, Jensen HB. Demonstration of lanthionine as a natural constituent of the peptidoglycan of Fusobacterium nucleatum. Infect Immun. 1979 Sep;25(3):775–780. [PMC free article] [PubMed]
  • Vasstrand EN, Jensen HB. Antibacterial properties of human lysozyme toward Fusobacterium nucleatum Fev1. Scand J Dent Res. 1984 Apr;92(2):109–119. [PubMed]
  • Vasstrand EN, Jensen HB, Miron T, Hofstad T. Composition of peptidoglycans in Bacteroidaceae: determination and distribution of lanthionine. Infect Immun. 1982 Apr;36(1):114–122. [PMC free article] [PubMed]
  • Vincent JW, Falkler WA, Jr, Cornett WC, Suzuki JB. Effect of periodontal therapy on specific antibody responses to suspected periodontopathogens. J Clin Periodontol. 1987 Aug;14(7):412–417. [PubMed]
  • Vincent JW, Suzuki JB, Falkler WA, Jr, Cornett WC. Reaction of human sera from juvenile periodontitis, rapidly progressive periodontitis, and adult periodontitis patients with selected periodontopathogens. J Periodontol. 1985 Aug;56(8):464–469. [PubMed]
  • Wahl SM, Costa GL, Mizel DE, Allen JB, Skaleric U, Mangan DF. Role of transforming growth factor beta in the pathophysiology of chronic inflammation. J Periodontol. 1993 May;64(5 Suppl):450–455. [PubMed]
  • Walsh LJ, Stritzel F, Yamazaki K, Bird PS, Gemmell E, Seymour GJ. Interleukin-1 and interleukin-1 inhibitor production by human adherent cells stimulated with periodontopathic bacteria. Arch Oral Biol. 1989;34(9):679–683. [PubMed]
  • Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991 Jan;173(2):697–703. [PMC free article] [PubMed]
  • Weiss MS, Abele U, Weckesser J, Welte W, Schiltz E, Schulz GE. Molecular architecture and electrostatic properties of a bacterial porin. Science. 1991 Dec 13;254(5038):1627–1630. [PubMed]
  • Weiss MS, Kreusch A, Schiltz E, Nestel U, Welte W, Weckesser J, Schulz GE. The structure of porin from Rhodobacter capsulatus at 1.8 A resolution. FEBS Lett. 1991 Mar 25;280(2):379–382. [PubMed]
  • Wikström M, Renvert S, Dahlén G, Johnsson T. Variance in recovery of periodontitis-associated bacteria caused by sampling technique and laboratory processing. Oral Microbiol Immunol. 1991 Apr;6(2):102–106. [PubMed]
  • Williams BL, Ebersole JL, Spektor MD, Page RC. Assessment of serum antibody patterns and analysis of subgingival microflora of members of a family with a high prevalence of early-onset periodontitis. Infect Immun. 1985 Sep;49(3):742–750. [PMC free article] [PubMed]
  • Williams JD, Maskell JP, Shain H, Chrysos G, Sefton AM, Fraser HY, Hardie JM. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. J Antimicrob Chemother. 1992 Jul;30(1):27–37. [PubMed]
  • Wilton JM, Johnson NW, Curtis MA, Gillett IR, Carman RJ, Bampton JL, Griffiths GS, Sterne JA. Specific antibody responses to subgingival plaque bacteria as aids to the diagnosis and prognosis of destructive periodontitis. J Clin Periodontol. 1991 Jan;18(1):1–15. [PubMed]
  • Winkler JR, John SR, Kramer RH, Hoover CI, Murray PA. Attachment of oral bacteria to a basement-membrane-like matrix and to purified matrix proteins. Infect Immun. 1987 Nov;55(11):2721–2726. [PMC free article] [PubMed]
  • Woese CR. Bacterial evolution. Microbiol Rev. 1987 Jun;51(2):221–271. [PMC free article] [PubMed]
  • Woese CR, Stackebrandt E, Macke TJ, Fox GE. A phylogenetic definition of the major eubacterial taxa. Syst Appl Microbiol. 1985;6:143–151. [PubMed]
  • Wyss C. Aspartame as a source of essential phenylalanine for the growth of oral anaerobes. FEMS Microbiol Lett. 1993 Apr 15;108(3):255–258. [PubMed]
  • Xie H, Gibbons RJ, Hay DI. Adhesive properties of strains of Fusobacterium nucleatum of the subspecies nucleatum, vincentii and polymorphum. Oral Microbiol Immunol. 1991 Oct;6(5):257–263. [PubMed]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...